This old version of Proteopedia is provided for student assignments while the new version is undergoing repairs. Content and edits done in this old version of Proteopedia after March 1, 2026 will eventually be lost when it is retired in about June of 2026.
Apply for new accounts at the new Proteopedia. Your logins will work in both the old and new versions.
Filamin
From Proteopedia
(Difference between revisions)
| Line 1: | Line 1: | ||
<StructureSection load='2wa5' size='350' side='right' scene='' caption='Human Filamin B actin-binding domain complex with sulfate and carbonate (PDB code [[2wa5]]) '> | <StructureSection load='2wa5' size='350' side='right' scene='' caption='Human Filamin B actin-binding domain complex with sulfate and carbonate (PDB code [[2wa5]]) '> | ||
| + | |||
| + | __TOC__ | ||
| + | |||
== Function == | == Function == | ||
| Line 10: | Line 13: | ||
Mutations in FLNA cause frontometaphyseal dysplasia, intestinal pseudo-obstruction, Melnick-Needles syndrome, otopalatodigital syndrome and periventricular heterotopia. Mutations in FLNAB cause boomerang dysplasia<ref>PMID:25614868</ref>. | Mutations in FLNA cause frontometaphyseal dysplasia, intestinal pseudo-obstruction, Melnick-Needles syndrome, otopalatodigital syndrome and periventricular heterotopia. Mutations in FLNAB cause boomerang dysplasia<ref>PMID:25614868</ref>. | ||
| + | |||
| + | ==3D structures of filamin== | ||
| + | [[Filamin 3D structures]] | ||
| + | |||
</StructureSection> | </StructureSection> | ||
==3D structures of filamin== | ==3D structures of filamin== | ||
| Line 16: | Line 23: | ||
{{#tree:id=OrganizedByTopic|openlevels=0| | {{#tree:id=OrganizedByTopic|openlevels=0| | ||
| - | * Filamin A | + | * Filamin A; Domains – ABD 1-278; 3-5 478-766; 10 1158-1252; 16 1772-1861; 17 1862-1955; 18 1954-2053; 19 2054-2141; 20 2142-2235; 21 2236-2329; 23 2427-2522; 24 2559-2647 |
| - | + | **[[2wfn]], [[3hop]], [[3hor]] – hFLNA ABD - human<br /> | |
| - | + | ||
| - | **[[2wfn]], [[3hop]], [[3hor]] – hFLNA ABD<br /> | + | |
**[[3hoc]] – hFLNA ABD (mutant)<br /> | **[[3hoc]] – hFLNA ABD (mutant)<br /> | ||
| + | **[[6d8c]] - hFLNA ABD (mutant) + actin + phalloidin – Cryo EM<br /> | ||
**[[4m9p]] - hFLNA domains 3-5<br /> | **[[4m9p]] - hFLNA domains 3-5<br /> | ||
| + | **[[6ew1]] - hFLNA domains 3-5 (mutant)<br /> | ||
| + | **[[3rgh]] - hFLNA domain 10<br /> | ||
**[[2aav]] - hFLNA domain 17 – NMR<br /> | **[[2aav]] - hFLNA domain 17 – NMR<br /> | ||
**[[2bp3]] - hFLNA domain 17+GPIB peptide<br /> | **[[2bp3]] - hFLNA domain 17+GPIB peptide<br /> | ||
| Line 30: | Line 38: | ||
**[[2w0p]], [[2mtp]] - hFLNA domain 21+migfilin peptide<br /> | **[[2w0p]], [[2mtp]] - hFLNA domain 21+migfilin peptide<br /> | ||
**[[2jf1]], [[2brq]] - hFLNA domain 21+integrin peptide<br /> | **[[2jf1]], [[2brq]] - hFLNA domain 21+integrin peptide<br /> | ||
| + | **[[3isw]] – hFLNA domain 21+CFTR peptide <br /> | ||
**[[2k3t]] - hFLNA domain 23 – NMR<br /> | **[[2k3t]] - hFLNA domain 23 – NMR<br /> | ||
| - | **[[3cnk]] - hFLNA | + | **[[3cnk]] - hFLNA domain 24<br /> |
* Filamin B | * Filamin B | ||
| Line 43: | Line 52: | ||
* Filamin C | * Filamin C | ||
| - | **[[2k9u]] – hFLNC+migfilin peptide<br /> | + | **[[3v8o]] - hFLNC domains 4,5 <br /> |
| + | **[[4mgx]] - hFLNC domains 4,5 + platelet glycoprotein peptide<br /> | ||
| + | **[[2k9u]] – hFLNC residues 919-1032 +migfilin peptide<br /> | ||
**[[2d7m]], [[2d7n]], [[2d7o]], [[2d7p]] - hFLNC domains 14, 16, 17, 22 - NMR<br /> | **[[2d7m]], [[2d7n]], [[2d7o]], [[2d7p]] - hFLNC domains 14, 16, 17, 22 - NMR<br /> | ||
**[[2nqc]] - hFLNC domain 21<br /> | **[[2nqc]] - hFLNC domain 21<br /> | ||
**[[2d7q]] - hFLNC domain 23 – NMR<br /> | **[[2d7q]] - hFLNC domain 23 – NMR<br /> | ||
| - | + | **[[1v05]] - hFLNC rod domain<br /> | |
| - | + | ||
| - | **[[1v05]] - hFLNC | + | |
* Other Filamins | * Other Filamins | ||
Revision as of 09:04, 1 July 2019
| |||||||||||
3D structures of filamin
Updated on 01-July-2019
References
- ↑ Clark AR, Sawyer GM, Robertson SP, Sutherland-Smith AJ. Skeletal dysplasias due to filamin A mutations result from a gain-of-function mechanism distinct from allelic neurological disorders. Hum Mol Genet. 2009 Dec 15;18(24):4791-800. Epub 2009 Sep 22. PMID:19773341 doi:10.1093/hmg/ddp442
- ↑ Sawyer GM, Clark AR, Robertson SP, Sutherland-Smith AJ. Disease-associated substitutions in the filamin B actin binding domain confer enhanced actin binding affinity in the absence of major structural disturbance: Insights from the crystal structures of filamin B actin binding domains. J Mol Biol. 2009 Jul 31;390(5):1030-47. Epub 2009 Jun 6. PMID:19505475 doi:10.1016/j.jmb.2009.06.009
- ↑ van der Flier A, Sonnenberg A. Structural and functional aspects of filamins. Biochim Biophys Acta. 2001 Apr 23;1538(2-3):99-117. PMID:11336782
- ↑ Brunetti-Pierri N, Torrado M, Fernandez Mdel C, Tello AM, Arberas CL, Cardinale A, Piccolo P, Bacino CA. Terminal osseous dysplasia with pigmentary defects (TODPD) due to a recurrent filamin A (FLNA) mutation. Mol Genet Genomic Med. 2014 Nov;2(6):467-71. doi: 10.1002/mgg3.90. Epub 2014 Aug , 8. PMID:25614868 doi:http://dx.doi.org/10.1002/mgg3.90
